Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria

Author:

Stillman MelissaORCID,Owolabi OnikepeORCID,Fatusi Adesegun OORCID,Akinyemi Akanni IORCID,Berry Amanda LORCID,Erinfolami Temitope PORCID,Olagunju Olalekan SORCID,Väisänen HeiniORCID,Bankole AkinrinolaORCID

Abstract

ObjectivesThis study aimed to assess the safety and effectiveness of self-managed misoprostol abortions obtained outside of the formal health system in Lagos State, Nigeria.DesignThis was a prospective cohort study among women using misoprostol-containing medications purchased from drug sellers. Three telephone-administered surveys were conducted over 1 month.SettingData were collected in 2018 in six local government areas in Lagos State.ParticipantsDrug sellers attempted to recruit all women who purchased misoprostol-containing medication. To remain in the study, participants had to be female and aged 18–49, and had to have purchased the medication for the purpose of abortion. Of 501 women initially recruited, 446 were eligible for the full study, and 394 completed all three surveys.Primary and secondary outcome measuresUsing self-reported measures, we assessed the quality of information provided by drug sellers; the prevalence of potential complications; and the proportion with completed abortions.ResultsAlthough drug sellers provided inadequate information about the pills, 94% of the sample reported a complete abortion without surgical intervention about 1 month after taking the medication. Assuming a conservative scenario where all individuals lost to follow-up had failed terminations, the completion rate dropped to 87%. While 86 women reported physical symptoms suggestive of complications, only six of them reported wanting or needing health facility care and four subsequently obtained care.ConclusionsDrug sellers are an important source of medical abortion in this setting. Despite the limitations of self-report, many women appear to have effectively self-administered misoprostol. Additional research is needed to expand the evidence on the safety and effectiveness of self-use of misoprostol for abortion in restrictive settings, and to inform approaches that support the health and well-being of people who use this method of abortion.

Funder

Ministerie van Buitenlandse Zaken

Anonymous Foundation

Government of the United Kingdom

Publisher

BMJ

Subject

General Medicine

Reference33 articles.

1. Singh S , Remez L , Sedgh G . Abortion worldwide 2017: uneven progress and unequal access. Guttmacher Institute, 2018.

2. World Health Organization . Medical management of abortion. Geneva: World Health Organization, 2018.

3. World Health Organization . Health worker roles in providing safe abortion care and post-abortion contraception. Geneva, Switzerland: World Health Organization, 2015.

4. United Nations, Department of Economic and Social Affairs, Population Division . World population prospects 2019. United Nations, 2019. https://population.un.org/wpp

5. Center for Reproductive Rights . The World’s Abortion Laws Map. no date. Available: https://reproductiverights.org/worldabortionlaws

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3